RFK Jr.'s Vaccine Panel Backs RSV Shot, Votes Against Flu Vaccine Preservative

CDC Vaccine Panel's First Decisions

• 🎯 The newly appointed vaccine advisory panel to the CDC, selected by Health and Human Services Secretary Robert F. Kennedy Jr., convened for its first official meeting.
• 🚀 The panel's primary action was approving recommendations for a new RSV shot targeting infants, following a recent FDA approval.

RSV Shot Approval Process

• 🔬 The RSV shot recommendation was presented as a window into the usual review process, involving months of rigorous review by CDC workgroups.
• 🤝 This process gathered input from experts and public health officials to understand the impact on stakeholders like health insurers, doctors, and parents, assessing safety and effectiveness.
• ✅ The committee ultimately signed off on the RSV shot recommendations by a majority vote, with only one dissenting member.

Flu Vaccine Preservative Controversy

• ⚠️ In contrast to the RSV shot, the panel voted to urge Americans to avoid flu vaccines containing thiomersal, a specific preservative.
• 🗣️ This decision was influenced by a presentation from Lynn Redwood, former head of Children's Health Defense, an organization previously associated with Robert F. Kennedy Jr.
• 📉 Critics expressed frustration that this recommendation bypassed the CDC's standard evidence-based processes, with a relevant CDC review being taken down.
• ❓ While thiomersal is rarely used in U.S. vaccines, the process raised concerns about potential bias and the bypassing of established data-gathering procedures.

Impact on Vaccine Coverage

• 💰 Decisions made by this committee are directly tied to federal law, dictating which vaccines health insurers are required to cover.
• 🛒 Changes in recommendations can affect vaccine costs and, more critically, lead to pharmacies and doctor's offices not stocking certain vaccines, making them harder to access.